Rada, M.; Craciun, M.-L.; Pah, A.-M.; Hogea, G.S.; Gurgus, D.; Velimirovici, M.D.; Surducan, D.A.; Mahmoud, A.; Utu, D.; Avram, C.-A.
Sodium–Glucose Cotransporter 2 Inhibitors in Valvular Heart Disease: Cardiovascular Benefit, Valve-Specific Effects, and Evidence Gaps—A Structured Narrative Review. J. Clin. Med. 2026, 15, 6355.
https://doi.org/10.3390/jcm15166355
AMA Style
Rada M, Craciun M-L, Pah A-M, Hogea GS, Gurgus D, Velimirovici MD, Surducan DA, Mahmoud A, Utu D, Avram C-A.
Sodium–Glucose Cotransporter 2 Inhibitors in Valvular Heart Disease: Cardiovascular Benefit, Valve-Specific Effects, and Evidence Gaps—A Structured Narrative Review. Journal of Clinical Medicine. 2026; 15(16):6355.
https://doi.org/10.3390/jcm15166355
Chicago/Turabian Style
Rada, Maria, Maria-Laura Craciun, Ana-Maria Pah, Gheorghe Stoichescu Hogea, Daniela Gurgus, Milan Daniel Velimirovici, Dan Alexandru Surducan, Abdeldayem Mahmoud, Diana Utu, and Cristiana-Adina Avram.
2026. "Sodium–Glucose Cotransporter 2 Inhibitors in Valvular Heart Disease: Cardiovascular Benefit, Valve-Specific Effects, and Evidence Gaps—A Structured Narrative Review" Journal of Clinical Medicine 15, no. 16: 6355.
https://doi.org/10.3390/jcm15166355
APA Style
Rada, M., Craciun, M.-L., Pah, A.-M., Hogea, G. S., Gurgus, D., Velimirovici, M. D., Surducan, D. A., Mahmoud, A., Utu, D., & Avram, C.-A.
(2026). Sodium–Glucose Cotransporter 2 Inhibitors in Valvular Heart Disease: Cardiovascular Benefit, Valve-Specific Effects, and Evidence Gaps—A Structured Narrative Review. Journal of Clinical Medicine, 15(16), 6355.
https://doi.org/10.3390/jcm15166355
